ProShares UltraPro Nasdaq Biotechnology (UBIO) Investment Research Dashboard
About ProShares UltraPro Nasdaq Biotechnology (UBIO) stock analysis
Get live UBIO stock price $17.77, comprehensive ProShares UltraPro Nasdaq Biotechnology stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time UBIO stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
This fund aims to deliver daily returns equal to three times (3x) the daily movement of the NASDAQ Biotechnology Index, prior to accounting for fees and operating costs. To achieve this, it strategically deploys capital into various financial instrum...
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Financial Services sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 3.15)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for ProShares UltraPro Nasdaq Biotechnology shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Financial Services may affect company performance
- ⚠Past performance does not guarantee future results for ProShares UltraPro Nasdaq Biotechnology
- ⚠Investors should consider how ProShares UltraPro Nasdaq Biotechnology fits within their overall portfolio allocation
Market Cap
15.09M
Beta
3.15
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare UBIO with peer companies:
- Price
- $41.63+0.00% (1D)
- Market cap
- 13.12M
- Price
- $38.51+0.00% (1D)
- Market cap
- 15.98M
- Price
- $20.01+0.00% (1D)
- Market cap
- 14.99M
- Price
- $110.05+0.00% (1D)
- Market cap
- 15.92M
- Price
- $4.65+26.36% (1D)
- Market cap
- 6.20M
- Price
- $45.91+0.00% (1D)
- Market cap
- 15.22M
- Price
- $32.69+0.00% (1D)
- Market cap
- 15.10M
- Price
- $43.73+0.00% (1D)
- Market cap
- 14.87M
- Price
- $60.40+0.00% (1D)
- Market cap
- 14.83M
- Price
- $53.08+0.00% (1D)
- Market cap
- 14.14M
About Financial Services Sector
The Financial Services sector includes companies that provide banking, insurance, investment, and other financial services to consumers and businesses.
Financial Services (1D)
84/100 ⭐⭐⭐⭐⭐
- Overall
- +0.4%
- NYSE
- +0.9%
- NASDAQ
- -0.2%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Communication Services | +0.9% | +3.9% | +3.2% | 22.2 | 94/100⭐⭐⭐⭐⭐ |
| Financial Services | +0.4% | +2.5% | +2.6% | 19.1 | 84/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.5% | +0.5% | +3.0% | 23.7 | 79/100⭐⭐⭐⭐⭐ |
| Energy | +1.4% | -1.7% | -1.3% | 19.6 | 64/100⭐⭐⭐⭐ |
| Consumer Defensive | -0.1% | +2.2% | +2.5% | 29.4 | 61/100⭐⭐⭐⭐ |
| Basic Materials | -0.2% | -0.8% | -2.8% | 25.0 | 50/100⭐⭐⭐ |
| Real Estate | -1.9% | -3.7% | -4.3% | 28.9 | 30/100⭐⭐ |
| Utilities | +0.6% | -5.3% | -5.1% | 26.7 | 30/100⭐⭐ |
| Consumer Cyclical | +0.3% | +0.5% | -7.0% | 43.0 | 27/100⭐⭐ |
| Technology | +2.3% | -3.1% | -8.4% | 42.0 | 22/100⭐ |
| Industrials | -0.5% | -3.5% | -12.5% | 29.7 | 10/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-31.